Japan's Takeda says CEO Weber to step down, raises profit forecast
Takeda Pharmaceutical said on Thursday its CEO Christophe Weber will retire after 12 years in management at Japan's biggest drugmaker. Julie Kim, president of the company's U.S. unit, was named to ...
Japan's Takeda says Q3 profit slid 38%, trailing analyst estimates
Japan's biggest drugmaker Takeda Pharmaceutical posted third-quarter profits on Thursday that trailed analyst estimates, as ...
Japan's Takeda raises full-year forecast after Q3 profit trails forecast
Japan's biggest drugmaker Takeda Pharmaceutical posted third-quarter profits on Thursday that trailed analyst estimates but ...
AZOM16h
Combining Structural Color with Superhydrophobicity for Next-Generation Coatings
Innovative structural color coatings from Chiba University combine hydrophobic melanin particles, offering long-lasting ...
Takeda Canada Announces Héma-Québec's Addition Of HyQvia To Plasma Product List
Takeda Canada Inc., the Canadian organization of Takeda Pharmaceutical Co. Ltd. (TAK) announced Wednesday that non-profit ...
Neurocrine announces amendment to collaboration with Takeda
Neurocrine Biosciences (NBIX) announced it has amended its agreement with Takeda (TAK) to develop and commercialize osavampator. Under the ...